Junjie Zhou
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Potential value of immunogenic cell death related-genes in refining European leukemiaNet guidelines classification and predicting the immune infiltration landscape in acute myeloid leukemia.
Journal: Cancer cell international
Published: March 20, 2024
Assessment of 2022 European LeukemiaNet risk classification system in real-world cohort from China.
Journal: Cancer medicine
Published: July 23, 2023
Bioinformatics analysis of the endoplasmic reticulum stress-related prognostic model and immune cell infiltration in acute myeloid leukemia.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 09, 2023
Dexamethasone enhances venetoclax-induced apoptosis in acute myeloid leukemia cells.
Journal: Medical oncology (Northwood, London, England)
Published: March 02, 2023
Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.
Journal: Frontiers in oncology
Published: August 24, 2022
Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19.
Journal: Frontiers in oncology
Published: April 16, 2022
NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma.
Journal: Frontiers in genetics
Published: September 06, 2021
Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature Review and Perspective.
Journal: Frontiers in immunology
Published: May 09, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026